世界の慢性うつ病パーソナリティ障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Depressive Personality Disorder Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1310
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、慢性うつ病パーソナリティ障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（選択的セロトニン再取り込み阻害薬、三環系抗うつ薬、ノルエピネフリン再取り込み阻害薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・慢性うつ病パーソナリティ障害治療の市場動向
・企業の競争状況、市場シェア
・慢性うつ病パーソナリティ障害治療の種類別市場規模（選択的セロトニン再取り込み阻害薬、三環系抗うつ薬、ノルエピネフリン再取り込み阻害薬、その他）
・慢性うつ病パーソナリティ障害治療の用途別市場規模（病院薬局、小売薬局、オンライン薬局）
・慢性うつ病パーソナリティ障害治療の北米市場規模2016-2027（アメリカ、カナダ）
・慢性うつ病パーソナリティ障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・慢性うつ病パーソナリティ障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・慢性うつ病パーソナリティ障害治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・慢性うつ病パーソナリティ障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Eli Lilly、Forest Laboratories、GlaxoSmithKline、Merck Sharp & Dohme、Pfizer、Allergan、Novartis）
・結論

Chronic depressive personality disorder also known as Dysthymia is a chronic form of depression. It is mild form of depression which last up to two years or more. This disorder is less severe in comparison to other forms of depression. Symptoms of chronic depressive personality disorder are loss of interest in daily activities, sadness, tiredness, trouble in concentrating and decision making, suicidal thoughts, and some others. Medication and psychotherapy are used for the management of chronic depressive personality disorder. Psychotherapy is preferred for children and adolescents instead of medication. But it also depend upon the severity of the chronic depressive personality disorder. Changing the lifestyle can also help in management of this disorder.
Chronic depressive personality disorder treatment market is expected driven by increasing prevalence and increasing diagnosis. Chronic depressive personality disorder is a chronic disorder as suggested by the name which require a long term treatment measures. Requirement for long term treatment is also expected to drive the growth of this market. Government initiatives and awareness programs are also expected to fuel the growth of chronic depressive personality disorder treatment market. Effectiveness of psychotherapy alone and non-medicated treatment option can be restraint in the growth of medicated chronic depressive personality disorder treatment market.

Market Analysis and Insights: Global Chronic Depressive Personality Disorder Treatment Market
The global Chronic Depressive Personality Disorder Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Depressive Personality Disorder Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Depressive Personality Disorder Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Depressive Personality Disorder Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Depressive Personality Disorder Treatment market.

Global Chronic Depressive Personality Disorder Treatment Scope and Market Size
Chronic Depressive Personality Disorder Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Depressive Personality Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Selective Serotonin Reuptake Inhibitors
Tricyclic Antidepressants
Norepinephrine Reuptake Inhibitors
Others

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eli Lilly
Forest Laboratories
GlaxoSmithKline
Merck Sharp & Dohme
Pfizer
Allergan
Novartis

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Depressive Personality Disorder Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Selective Serotonin Reuptake Inhibitors
1.2.3 Tricyclic Antidepressants
1.2.4 Norepinephrine Reuptake Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chronic Depressive Personality Disorder Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Depressive Personality Disorder Treatment Market Perspective (2016-2027)
2.2 Chronic Depressive Personality Disorder Treatment Growth Trends by Regions
2.2.1 Chronic Depressive Personality Disorder Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Depressive Personality Disorder Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Depressive Personality Disorder Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Depressive Personality Disorder Treatment Industry Dynamic
2.3.1 Chronic Depressive Personality Disorder Treatment Market Trends
2.3.2 Chronic Depressive Personality Disorder Treatment Market Drivers
2.3.3 Chronic Depressive Personality Disorder Treatment Market Challenges
2.3.4 Chronic Depressive Personality Disorder Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Depressive Personality Disorder Treatment Players by Revenue
3.1.1 Global Top Chronic Depressive Personality Disorder Treatment Players by Revenue (2016-2021)
3.1.2 Global Chronic Depressive Personality Disorder Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Depressive Personality Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Depressive Personality Disorder Treatment Revenue
3.4 Global Chronic Depressive Personality Disorder Treatment Market Concentration Ratio
3.4.1 Global Chronic Depressive Personality Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Depressive Personality Disorder Treatment Revenue in 2020
3.5 Chronic Depressive Personality Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Depressive Personality Disorder Treatment Product Solution and Service
3.7 Date of Enter into Chronic Depressive Personality Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Depressive Personality Disorder Treatment Breakdown Data by Type
4.1 Global Chronic Depressive Personality Disorder Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chronic Depressive Personality Disorder Treatment Forecasted Market Size by Type (2022-2027)

5 Chronic Depressive Personality Disorder Treatment Breakdown Data by Application
5.1 Global Chronic Depressive Personality Disorder Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chronic Depressive Personality Disorder Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Depressive Personality Disorder Treatment Market Size (2016-2027)
6.2 North America Chronic Depressive Personality Disorder Treatment Market Size by Type
6.2.1 North America Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2021)
6.2.2 North America Chronic Depressive Personality Disorder Treatment Market Size by Type (2022-2027)
6.2.3 North America Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2027)
6.3 North America Chronic Depressive Personality Disorder Treatment Market Size by Application
6.3.1 North America Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2021)
6.3.2 North America Chronic Depressive Personality Disorder Treatment Market Size by Application (2022-2027)
6.3.3 North America Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2027)
6.4 North America Chronic Depressive Personality Disorder Treatment Market Size by Country
6.4.1 North America Chronic Depressive Personality Disorder Treatment Market Size by Country (2016-2021)
6.4.2 North America Chronic Depressive Personality Disorder Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Chronic Depressive Personality Disorder Treatment Market Size (2016-2027)
7.2 Europe Chronic Depressive Personality Disorder Treatment Market Size by Type
7.2.1 Europe Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chronic Depressive Personality Disorder Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2027)
7.3 Europe Chronic Depressive Personality Disorder Treatment Market Size by Application
7.3.1 Europe Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chronic Depressive Personality Disorder Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2027)
7.4 Europe Chronic Depressive Personality Disorder Treatment Market Size by Country
7.4.1 Europe Chronic Depressive Personality Disorder Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chronic Depressive Personality Disorder Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Type
8.2.1 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Application
8.3.1 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Region
8.4.1 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Depressive Personality Disorder Treatment Market Size (2016-2027)
9.2 Latin America Chronic Depressive Personality Disorder Treatment Market Size by Type
9.2.1 Latin America Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Depressive Personality Disorder Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2027)
9.3 Latin America Chronic Depressive Personality Disorder Treatment Market Size by Application
9.3.1 Latin America Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Depressive Personality Disorder Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2027)
9.4 Latin America Chronic Depressive Personality Disorder Treatment Market Size by Country
9.4.1 Latin America Chronic Depressive Personality Disorder Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Depressive Personality Disorder Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Type
10.2.1 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Application
10.3.1 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Country
10.4.1 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Chronic Depressive Personality Disorder Treatment Introduction
11.1.4 Eli Lilly Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
11.1.5 Eli Lilly Recent Development
11.2 Forest Laboratories
11.2.1 Forest Laboratories Company Details
11.2.2 Forest Laboratories Business Overview
11.2.3 Forest Laboratories Chronic Depressive Personality Disorder Treatment Introduction
11.2.4 Forest Laboratories Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
11.2.5 Forest Laboratories Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Chronic Depressive Personality Disorder Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Merck Sharp & Dohme
11.4.1 Merck Sharp & Dohme Company Details
11.4.2 Merck Sharp & Dohme Business Overview
11.4.3 Merck Sharp & Dohme Chronic Depressive Personality Disorder Treatment Introduction
11.4.4 Merck Sharp & Dohme Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
11.4.5 Merck Sharp & Dohme Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Chronic Depressive Personality Disorder Treatment Introduction
11.5.4 Pfizer Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Allergan
11.6.1 Allergan Company Details
11.6.2 Allergan Business Overview
11.6.3 Allergan Chronic Depressive Personality Disorder Treatment Introduction
11.6.4 Allergan Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
11.6.5 Allergan Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Chronic Depressive Personality Disorder Treatment Introduction
11.7.4 Novartis Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
11.7.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Depressive Personality Disorder Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Selective Serotonin Reuptake Inhibitors
Table 3. Key Players of Tricyclic Antidepressants
Table 4. Key Players of Norepinephrine Reuptake Inhibitors
Table 5. Key Players of Others
Table 6. Global Chronic Depressive Personality Disorder Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Chronic Depressive Personality Disorder Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Chronic Depressive Personality Disorder Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Chronic Depressive Personality Disorder Treatment Market Share by Regions (2016-2021)
Table 10. Global Chronic Depressive Personality Disorder Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Chronic Depressive Personality Disorder Treatment Market Share by Regions (2022-2027)
Table 12. Chronic Depressive Personality Disorder Treatment Market Trends
Table 13. Chronic Depressive Personality Disorder Treatment Market Drivers
Table 14. Chronic Depressive Personality Disorder Treatment Market Challenges
Table 15. Chronic Depressive Personality Disorder Treatment Market Restraints
Table 16. Global Chronic Depressive Personality Disorder Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Chronic Depressive Personality Disorder Treatment Market Share by Players (2016-2021)
Table 18. Global Top Chronic Depressive Personality Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Depressive Personality Disorder Treatment as of 2020)
Table 19. Ranking of Global Top Chronic Depressive Personality Disorder Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Chronic Depressive Personality Disorder Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Depressive Personality Disorder Treatment Product Solution and Service
Table 23. Date of Enter into Chronic Depressive Personality Disorder Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Chronic Depressive Personality Disorder Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Chronic Depressive Personality Disorder Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Chronic Depressive Personality Disorder Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Chronic Depressive Personality Disorder Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Chronic Depressive Personality Disorder Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Chronic Depressive Personality Disorder Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Chronic Depressive Personality Disorder Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Chronic Depressive Personality Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Chronic Depressive Personality Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Chronic Depressive Personality Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Chronic Depressive Personality Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Chronic Depressive Personality Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Chronic Depressive Personality Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Chronic Depressive Personality Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Chronic Depressive Personality Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Chronic Depressive Personality Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Chronic Depressive Personality Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Chronic Depressive Personality Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Chronic Depressive Personality Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eli Lilly Company Details
Table 64. Eli Lilly Business Overview
Table 65. Eli Lilly Chronic Depressive Personality Disorder Treatment Product
Table 66. Eli Lilly Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021) & (US$ Million)
Table 67. Eli Lilly Recent Development
Table 68. Forest Laboratories Company Details
Table 69. Forest Laboratories Business Overview
Table 70. Forest Laboratories Chronic Depressive Personality Disorder Treatment Product
Table 71. Forest Laboratories Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021) & (US$ Million)
Table 72. Forest Laboratories Recent Development
Table 73. GlaxoSmithKline Company Details
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Chronic Depressive Personality Disorder Treatment Product
Table 76. GlaxoSmithKline Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021) & (US$ Million)
Table 77. GlaxoSmithKline Recent Development
Table 78. Merck Sharp & Dohme Company Details
Table 79. Merck Sharp & Dohme Business Overview
Table 80. Merck Sharp & Dohme Chronic Depressive Personality Disorder Treatment Product
Table 81. Merck Sharp & Dohme Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021) & (US$ Million)
Table 82. Merck Sharp & Dohme Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Chronic Depressive Personality Disorder Treatment Product
Table 86. Pfizer Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Allergan Company Details
Table 89. Allergan Business Overview
Table 90. Allergan Chronic Depressive Personality Disorder Treatment Product
Table 91. Allergan Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021) & (US$ Million)
Table 92. Allergan Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Chronic Depressive Personality Disorder Treatment Product
Table 96. Novartis Revenue in Chronic Depressive Personality Disorder Treatment Business (2016-2021) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Depressive Personality Disorder Treatment Market Share by Type: 2020 VS 2027
Figure 2. Selective Serotonin Reuptake Inhibitors Features
Figure 3. Tricyclic Antidepressants Features
Figure 4. Norepinephrine Reuptake Inhibitors Features
Figure 5. Others Features
Figure 6. Global Chronic Depressive Personality Disorder Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Online Pharmacy Case Studies
Figure 10. Chronic Depressive Personality Disorder Treatment Report Years Considered
Figure 11. Global Chronic Depressive Personality Disorder Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Chronic Depressive Personality Disorder Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Chronic Depressive Personality Disorder Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Chronic Depressive Personality Disorder Treatment Market Share by Regions (2022-2027)
Figure 15. Global Chronic Depressive Personality Disorder Treatment Market Share by Players in 2020
Figure 16. Global Top Chronic Depressive Personality Disorder Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Depressive Personality Disorder Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Chronic Depressive Personality Disorder Treatment Revenue in 2020
Figure 18. Global Chronic Depressive Personality Disorder Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Chronic Depressive Personality Disorder Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Chronic Depressive Personality Disorder Treatment Market Share by Type (2016-2027)
Figure 22. North America Chronic Depressive Personality Disorder Treatment Market Share by Application (2016-2027)
Figure 23. North America Chronic Depressive Personality Disorder Treatment Market Share by Country (2016-2027)
Figure 24. United States Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Chronic Depressive Personality Disorder Treatment Market Share by Type (2016-2027)
Figure 28. Europe Chronic Depressive Personality Disorder Treatment Market Share by Application (2016-2027)
Figure 29. Europe Chronic Depressive Personality Disorder Treatment Market Share by Country (2016-2027)
Figure 30. Germany Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Chronic Depressive Personality Disorder Treatment Market Share by Region (2016-2027)
Figure 40. China Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Chronic Depressive Personality Disorder Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Chronic Depressive Personality Disorder Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Chronic Depressive Personality Disorder Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Chronic Depressive Personality Disorder Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Chronic Depressive Personality Disorder Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Eli Lilly Revenue Growth Rate in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
Figure 60. Forest Laboratories Revenue Growth Rate in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
Figure 62. Merck Sharp & Dohme Revenue Growth Rate in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
Figure 63. Pfizer Revenue Growth Rate in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
Figure 64. Allergan Revenue Growth Rate in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Chronic Depressive Personality Disorder Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の大うつ病性障害市場規模・現状・予測（2021年-2027年）

Global Major Depressive Disorder Market Size, Status and Forecast 2021-2027
QYR2104Z3529 2021年4月 96Pages
QYResearch社発行の本調査資料では、大うつ病性障害のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、生物学的療法、瞑想、理学療法、その他）、用途別市場規模（25歳以下、25〜45歳、45歳以上）、主要地域別市場規模（北米、アメリ...

世界の大うつ病性障害（MDD）市場規模・現状・予測（2021年-2027年）

Global Major Depressive Disorder (MDD) Market Size, Status and Forecast 2021-2027
QYR2104Z3528 2021年4月 99Pages
QYResearch社発行の本調査資料では、大うつ病性障害（MDD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗うつ薬、SSRI、SNRI、ベンゾジアゼピン、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、...

世界のうつ病性障害市場規模・現状・予測（2021年-2027年）

Global Depressive Disorder Market Size, Status and Forecast 2021-2027
QYR2104Z1800 2021年4月 97Pages
QYResearch社発行の本調査資料では、うつ病性障害のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（三環系抗うつ薬、選択的セロトニン再取り込み阻害薬、セロトニン-ノルエピネフリン再取り込み阻害薬、モノアミン酸化酵素阻害薬、セロトニン拮抗薬・...

世界の大うつ病性障害治療市場規模・現状・予測（2021年-2027年）

Global Major Depressive Disorder Therapeutic Market Size, Status and Forecast 2021-2027
QYR2104Z3530 2021年4月 91Pages
QYResearch社発行の本調査資料では、大うつ病性障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、生物学的療法、瞑想、理学療法、その他）、用途別市場規模（25歳以下、25〜45歳、45歳以上）、主要地域別市場規模（北米、ア...

世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年）

Global Chronic Obstructive Pulmonary Disorder Market Size, Status and Forecast 2021-2027
QYR2104Z1326 2021年4月 99Pages
QYResearch社発行の本調査資料では、慢性閉塞性肺疾患（COPD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（短時間作用型気管支拡張薬、コルチコステロイド、メチルキサンチン、長時間作用型気管支拡張薬、ホスホジエステラーゼ-4阻害薬、そ...

世界の慢性閉塞性肺疾患（COPD）市場規模・現状・予測（2021年-2027年）

Global Chronic Obstructive Pulmonary Disorder (COPD) Market Size, Status and Forecast 2021-2027
QYR2104Z1325 2021年4月 96Pages
QYResearch社発行の本調査資料では、慢性閉塞性肺疾患（COPD）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（短時間作用型気管支拡張薬、コルチコステロイド、メチルキサンチン、長時間作用型気管支拡張薬、ホスホジエステラーゼ-4阻害薬、そ...

世界の甲状腺障害治療市場規模・現状・予測（2021年-2027年）

Global Thyroid Gland Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5652 2021年4月 92Pages
QYResearch社発行の本調査資料では、甲状腺障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（甲状腺機能亢進症、甲状腺機能低下症、その他）、用途別市場規模（男性、女性）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、...

世界の脂質障害治療市場規模・現状・予測（2021年-2027年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3432 2021年4月 98Pages
QYResearch社発行の本調査資料では、脂質障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他）、用途別市場規模（病院、クリニック、その他）、主要...

世界の耳鼻咽喉科疾患治療市場規模・現状・予測（2021年-2027年）

Global ENT Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2192 2021年4月 92Pages
QYResearch社発行の本調査資料では、耳鼻咽喉科疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（扁桃炎、耳感染症、副鼻腔感染症、睡眠時無呼吸）、用途別市場規模（病院、診療所、外来手術センター、在宅ケア施設、その他）、主要地域別市場...

世界の季節性情動障害治療市場規模・現状・予測（2021年-2027年）

Global Seasonal Affective Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5145 2021年4月 95Pages
QYResearch社発行の本調査資料では、季節性情動障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（光線療法、医薬品、心理療法、カウンセリング、その他）、用途別市場規模（病院、診療所、医学研究センター、その他）、主要地域別市場規模（北...

世界のうつ病性障害市場規模・現状・予測（2021年-2027年） Depression includes a variety of mental health problems characterized by the absence of a positive emotion, low mood, and a range of associated cognitive, physical, emotional, and behavioral symptoms. It is a very common condition that affects 1 in every 5 Americans. There are many factors including…
世界の大うつ病性障害市場規模・現状・予測（2021年-2027年） Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, …
世界の大うつ病性障害（MDD）市場規模・現状・予測（2021年-2027年） Major Depressive Disorder (MDD) is a common mental illness characterized by persistent low mood that interferes with the person's ability to eat, work, sleep and other activities. MDD is also referred to as clinical depression or recurrent depression. The common symptoms of this mental disorder are …
世界の大うつ病性障害治療市場規模・現状・予測（2021年-2027年） Major depressive disorder, also known as major depression and clinical depression, is a mental disorder characterized by loss of interest and pleasure in enjoyable environment. People are affected in different ways by major depression. Some people have trouble sleeping, feel agitated and irritable, …
世界の双極性障害治療市場規模・現状・予測（2021年-2027年） Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood. The treatment of bipolar disorder includes psychotherapy as well as medications such as mood stabilizers and antipsychotics. Market Analysis and Insights: Global Bipolar…